P
QGENF

Pitcairn’s QIAGEN NV QGENF Stock Holding History

Pitcairn’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-9,861
Closed -$277K – 532
2016
Q4 		$277K Sell
9,861
-389
-4% -$10.9K 0.03% 394
2016
Q3 		$281K Sell
10,250
-2,654
-21% -$72.8K 0.04% 389
2016
Q2 		$281K Sell
12,904
-25,753
-67% -$561K 0.04% 356
2016
Q1 		$863K Sell
38,657
-6,529
-14% -$146K 0.11% 152
2015
Q4 		$1.25M Sell
45,186
-2,672
-6% -$73.9K 0.14% 111
2015
Q3 		$1.24M Sell
47,858
-3,052
-6% -$78.8K 0.16% 105
2015
Q2 		$1.26M Sell
50,910
-2,146
-4% -$53.2K 0.15% 124
2015
Q1 		$1.34M Sell
53,056
-2,161
-4% -$54.5K 0.15% 118
2014
Q4 		$1.29M Sell
55,217
-723
-1% -$17K 0.14% 127
2014
Q3 		$1.27M Sell
55,940
-2,459
-4% -$56K 0.14% 122
2014
Q2 		$1.43M Sell
58,399
-3,015
-5% -$73.7K 0.16% 116
2014
Q1 		$1.29M Sell
61,414
-4,661
-7% -$98.3K 0.14% 120
2013
Q4 		$1.57M Sell
66,075
-2,842
-4% -$67.7K 0.17% 105
2013
Q3 		$1.48M Sell
68,917
-533
-0.8% -$11.4K 0.18% 104
2013
Q2 		$1.38M Buy
+69,450
New +$1.38M 0.19% 114

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Pitcairn's QGENF Position: Q1 2017 in Review

Pitcairn sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 9,861 shares — an estimated $277K sold.

Pitcairn first reported a position in QGENF in Q2 2013 and held it in 15 quarters. The position peaked at $1.57M in Q4 2013. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Pitcairn reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Pitcairn sold 9,861 QIAGEN NV shares in Q1 2017, an estimated $277K.
  • Pitcairn first reported a position in QIAGEN NV in Q2 2013 and held it in 15 quarters.
  • Pitcairn's QIAGEN NV position peaked at $1.57M in Q4 2013.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Pitcairn's 13F filing for Q1 2017, filed 8 May 2017.